Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways.
about
Functional effects of PTPN11 (SHP2) mutations causing LEOPARD syndrome on epidermal growth factor-induced phosphoinositide 3-kinase/AKT/glycogen synthase kinase 3beta signalingActivated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy.Molecular and cellular mechanisms of cardiotoxicity.Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitroEpac enhances excitation-transcription coupling in cardiac myocytesDifferential and combined effects of cardiotrophin-1 and TGF-beta1 on cardiac myofibroblast proliferation and contractionGenetic reduction of embryonic leukemia-inhibitory factor production rescues placentation in SOCS3-null embryos but does not prevent inflammatory diseaseAttenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-discA novel miniaturized multimodal bioreactor for continuous in situ assessment of bioartificial cardiac tissue during stimulation and maturation.Methods in cardiomyocyte isolation, culture, and gene transfer.Differential Signaling and Hypertrophic Responses in Cyclically Stretched vs Endothelin-1 Stimulated Neonatal Rat Cardiomyocytes.Intramyocardial fibroblast myocyte communication.Gastrodin Inhibits Store-Operated Ca2+ Entry and Alleviates Cardiac Hypertrophy.Cardiotrophin-1 (CT-1): a novel hypertrophic and cardioprotective agent.Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy.Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.Receptor recognition by gp130 cytokines.Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndromeA dominantly negative mutation in cardiac troponin I at the interface with troponin T causes early remodeling in ventricular cardiomyocytesInterleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats.beta-blocker therapy: a standard of care for heart failure.Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectivesIdentification of a tetrahydroquinoline analog as a pharmacological inhibitor of the cAMP-binding protein Epac.Function and signal transduction mediated by the interleukin 3 receptor system in hematopoiesis.Trypanosoma cruzi infection and nuclear factor kappa B activation prevent apoptosis in cardiac cellsThe gp130 receptor cytokine family: regulators of adipocyte development and function.The inhibition of N-glycosylation of glycoprotein 130 molecule abolishes STAT3 activation by IL-6 family cytokines in cultured cardiac myocytes.The lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury response.Ventricular arrhythmias: antiadrenergic therapy for the patient with coronary artery disease.The varying faces of IL-6: From cardiac protection to cardiac failure.Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspectsAnchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy.Identification of a core set of genes that signifies pathways underlying cardiac hypertrophy.Update on the pathophysiological activities of the cardiac molecule cardiotrophin-1 in obesity.Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: Mechanisms and model systems.LIF and the heart: just another brick in the wall?Isolation and characterization of the chicken m2 acetylcholine receptor promoter region: induction of gene transcription by leukemia inhibitory factor and ciliary neurotrophic factor.Circulating biomarker responses to medical management vs. mechanical circulatory support in severe inotrope-dependent acute heart failure.Interleukin 6 regulates psoriasiform inflammation-associated thrombosis.
P2860
Q24304242-B95AE7D4-544C-47A9-A772-F5696E59E0DBQ24535352-3A39D34E-09CA-4E38-AF28-68888A5AA047Q24814079-0F1981BF-0E37-482D-9A31-D156218DD1C8Q28296128-8193794D-3333-44F8-BF15-32508130E6BEQ28344062-37F9C1AE-2233-45E8-8B05-20D29CA8079FQ28565123-6B905B9B-01B2-4F74-BB2C-E6D1A22E6715Q28569329-7A6FCC1E-FDAD-40E3-89D1-1AFCC98D5D88Q28592478-D219DF22-6851-46CB-B5DB-19989556466AQ28593396-77AD3344-B332-4B03-BC52-2C78674FA417Q30500611-B96DAAFC-9E6F-4ED0-A456-39BF9CC78267Q30503890-29BE175D-474F-4347-857C-7369ED56C41AQ33280925-30D8C0AC-D1C3-4702-BC13-A5652A70E392Q33586605-D52E15F9-CBC1-4830-9A9B-2FFB944C5224Q33601764-75363D99-9B3B-497A-AB6F-D4609C8D3CE2Q33785805-8F8394E0-C8A7-4306-B544-7EA227217108Q33859087-C6E67A01-C209-4081-9BE5-58A7C5C5BA2AQ33863961-14859B57-D452-4DBC-85B5-40F751D679EBQ33931723-4C01F427-CE26-488D-9F13-EE969FE7D926Q34032238-E409B347-5B30-458E-81EE-6FA16EB7BDEAQ34062888-B17657E7-C952-4E44-856F-B33FAB7E9A6AQ34066697-F574BC43-D570-4A1E-9596-63908E844E24Q34088204-F6ED4FB9-1C15-4723-A6CB-7CA66FD68B78Q34289211-BFB64FD1-26DF-450F-B2EA-0986976102D2Q34310769-DF3D20EE-2621-4EFD-9710-3706E2FD3F40Q34409824-9C3A8967-3468-421B-930B-5FF03E56C1ADQ34491767-B0C24366-D424-4992-9C68-95BB1CA44585Q35059389-6C3CAAE3-DF33-4D40-9881-DA886B0AD526Q35361479-86BD66D2-058A-46C3-AA5B-8F2B6BD2B664Q35633386-F2CB4208-AC41-4020-92EE-7FE93CFE347DQ36167677-ED297CAE-AB98-4126-9582-183C2077FF38Q36368339-B38B04F9-3798-455A-81DF-B6871BD412EBQ36497007-95E4EDE4-D523-4041-B51C-5714104B9FB8Q36510904-B107C4B4-7160-4117-BFD1-6BC3A955EDB1Q36748674-015F9077-D2BA-46B9-A1E0-71ED8E6B65FDQ36830891-FAE14077-6D9A-4141-B6F7-A310013718F2Q36885445-20091993-791C-4883-ABCE-618A2B87D9BEQ36907315-72BC3D86-5E4C-4661-9AAD-43A2AD381C10Q37055795-26B0E12A-76E7-4A4B-9C97-67CC6A033405Q37337332-B9FA2BC2-B222-4829-8AFF-1143CE9D9A61Q37469175-879DD41E-3E62-4F58-9FFF-85911EBC79EF
P2860
Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Cardiotrophin-1 activates a di ...... r receptor-dependent pathways.
@en
type
label
Cardiotrophin-1 activates a di ...... r receptor-dependent pathways.
@en
prefLabel
Cardiotrophin-1 activates a di ...... r receptor-dependent pathways.
@en
P2093
P356
P1476
Cardiotrophin-1 activates a di ...... r receptor-dependent pathways.
@en
P2093
A B Vernallis
C C Glembotski
K C Wollert
M Narazaki
T Kishimoto
P304
P356
10.1074/JBC.271.16.9535
P407
P577
1996-04-01T00:00:00Z